Anteilseigner
Driehaus Capital Management LLC (7,54 %) BlackRock Fund Advisors (7,19 %) EcoR1 Capital, LLC (5,86 %) Fidelity Management & Research Co. LLC (5,52 %) SSgA Funds Management, Inc. (5,33 %) Point72 Asset Management LP (5,12 %) The Vanguard Group, Inc. (5,09 %) Wellington Management Co. LLP (4,86 %) T. Rowe Price Associates, Inc. (Investment Management) (4,41 %) Jennison Associates LLC (3,81 %) T. Rowe Price Investment Management, Inc. (3,62 %) Paradigm BioCapital Advisors LP (3,46 %) First Light Asset Management LLC (2,98 %) OrbiMed Advisors Private Equity (2,50 %) Perceptive Advisors LLC (2,21 %) Geode Capital Management LLC (2,02 %) Bain Capital Life Sciences LP (1,91 %) Cormorant Asset Management LP (1,72 %) Scott R. Struthers (1,71 %) Novo Holdings A/ S (Investment Company) (1,65 %)
Kontakt
CRINETICS PHARMACEUTICALS INC